NCT04900220View on ClinicalTrials.gov

Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections

PHASE4CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

September 15, 2021

Primary Completion Date

December 27, 2022

Study Completion Date

April 10, 2023

Conditions
Trigger Finger
Interventions
DRUG

Betamethasone

The volume of the doses of steroid to be given will be standardized to 1 injection of 1 cc of betamethasone (6 mg)

DRUG

Methylprednisolone

The volume of the doses of steroid to be given will be standardized to 1 injection of 1 cc of methylprednisolone (40 mg)

Trial Locations (2)

26501

WVU Medicine University Town Center, Morgantown

26506

Ruby Memorial Hospital or Other WVU Healthcare Site, Morgantown

All Listed Sponsors
lead

West Virginia University

OTHER

NCT04900220 - Differences in Flare Reaction Incidence and Intensity Following Trigger Finger Injections | Biotech Hunter | Biotech Hunter